Stock APDN APPLIED DNA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Applied DNA Sciences, Inc.

Equities

APDN

US03815U3005

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
0.29 USD -12.12% Intraday chart for Applied DNA Sciences, Inc. -15.77% -52.98%
Apr. 03 Certain Warrants of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024. CI
Apr. 03 Certain Options of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024. CI

Business Summary

Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.

Number of employees: 54

Sales per Business

USD in Million2022Weight2023Weight Delta
Molecular Diagnostics Testing Services
83.4 %
16 88.9 % 11 83.4 % -30.97%
Deoxyribonucleic Acid Tagging and Security Products
8.6 %
2 8.7 % 1 8.6 % -27.03%
Therapeutic Deoxyribonucleic Acid Production
8.0 %
0 2.4 % 1 8.0 % +142.69%

Sales per region

USD in Million2022Weight2023Weight Delta
Americas
91.4 %
18 96.6 % 12 91.4 % -30.33%
Asia and Other
6.6 %
0 1.0 % 1 6.6 % +405.42%
Europe
1.9 %
0 2.5 % 0 1.9 % -42.44%

Managers

Managers TitleAgeSince
James Hayward CEO
 Chief Executive Officer 71 05-09-27
Beth Jantzen DFI
 Director of Finance/CFO 47 13-04-30
Lawrence Jung CTO
 Chief Tech/Sci/R&D Officer - -
Judy Murrah COO
 Chief Operating Officer 66 13-05-31
Sanjay Hurry IRC
 Investor Relations Contact - 20-07-14
Frank Cipriani PRN
 Corporate Officer/Principal - -
Wayne Buchen SAM
 Sales & Marketing - 18-10-03
Clay Shorrock LAW
 General Counsel 40 15-12-31

Members of the board

Members of the board TitleAgeSince
Yacov Shamash BRD
 Director/Board Member 74 06-03-16
Bob Catell BRD
 Director/Board Member 87 16-10-06
James Hayward CEO
 Chief Executive Officer 71 05-09-27
Sanford Simon BRD
 Director/Board Member 81 06-03-16
Joseph Ceccoli BRD
 Director/Board Member 60 14-12-02
Elizabeth Schmalz Shaheen BRD
 Director/Board Member 72 17-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,042,003 14,887,518 ( 87.36 %) 63,300 ( 0.3714 %) 87.36 %

Shareholders

NameEquities%Valuation
Bruce Grossman
9.817 %
1,666,798 9.817 % 683 387 $
Armistice Capital LLC
9.200 %
1,561,995 9.200 % 640 418 $
Vanguard Global Advisers LLC
3.084 %
523,691 3.084 % 214 713 $
AMH Equity Ltd.
2.179 %
370,000 2.179 % 151 700 $
Geode Capital Management LLC
0.8198 %
139,187 0.8198 % 57 067 $
James Hayward
0.7903 %
134,186 0.7903 % 55 016 $
Judy Murrah
0.5999 %
101,853 0.5999 % 41 760 $
BlackRock Institutional Trust Co. NA
0.5966 %
101,295 0.5966 % 41 531 $
Silverberg Bernstein Capital Management LLC
0.5790 %
98,301 0.5790 % 40 303 $
Cowen Prime Advisors LLC
0.5790 %
98,301 0.5790 % 40 303 $

Company contact information

Applied DNA Sciences, Inc.

50 Health Sciences Drive

11790, Stony Brook

+631 240 8800

http://www.adnas.com
address Applied DNA Sciences, Inc.(APDN)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Diagnostic & Testing Substances

Sales per Business

Sales per region

Ratings for Applied DNA Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.29 USD
Average target price
2.25 USD
Spread / Average Target
+675.86%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
APPLIED DNA SCIENCES, INC. Stock Applied DNA Sciences, Inc.
-52.98% 5.01M
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-12.75% 7.4B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+3.28% 5.47B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-1.37% 4.51B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+3.89% 4.42B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.71% 3.29B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+9.29% 2.66B
VITROLIFE AB Stock Vitrolife AB
-14.38% 2.07B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
-2.82% 1.68B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-14.72% 1.66B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. APDN Stock
  4. Company Applied DNA Sciences, Inc.